Non-invasive in vivo assessment of IDH1 mutational status in glioma

[1]  J. Berwick,et al.  Kinetic modeling of hyperpolarized 13C pyruvate metabolism in tumors using a measured arterial input function , 2013, Magnetic resonance in medicine.

[2]  Adam B Kerr,et al.  Optimal variable flip angle schemes for dynamic acquisition of exchanging hyperpolarized substrates. , 2013, Journal of magnetic resonance.

[3]  John Kurhanewicz,et al.  Combined parallel and partial fourier MR reconstruction for accelerated 8‐channel hyperpolarized carbon‐13 in vivo magnetic resonance Spectroscopic imaging (MRSI) , 2013, Journal of magnetic resonance imaging : JMRI.

[4]  P. Larson,et al.  Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.

[5]  Fang Wang,et al.  An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells , 2013, Science.

[6]  W. Kaelin,et al.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. , 2013, Genes & development.

[7]  T. Bathen,et al.  2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping. , 2013, Translational oncology.

[8]  O. Abdel-Wahab,et al.  The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization* , 2012, The Journal of Biological Chemistry.

[9]  P. Kleihues,et al.  The Definition of Primary and Secondary Glioblastoma , 2012, Clinical Cancer Research.

[10]  T. Cloughesy,et al.  Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. , 2012, Neuro-oncology.

[11]  Hui Yang,et al.  IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives , 2012, Clinical Cancer Research.

[12]  S. Gross,et al.  Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo. , 2012, ACS medicinal chemistry letters.

[13]  K. Smolková,et al.  The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells , 2012, International journal of cell biology.

[14]  Margarida Julià-Sapé,et al.  Prospective diagnostic performance evaluation of single‐voxel 1H MRS for typing and grading of brain tumours , 2012, NMR in biomedicine.

[15]  C. Rock,et al.  Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation* , 2012, The Journal of Biological Chemistry.

[16]  A. Viale,et al.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.

[17]  Erwin G. Van Meir,et al.  Detection of “oncometabolite” 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma , 2012, Journal of Molecular Medicine.

[18]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[19]  S. Weiss,et al.  An in vivo patient-derived model of endogenous IDH1-mutant glioma. , 2012, Neuro-oncology.

[20]  N. Alon,et al.  Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors. , 2012, Cancer research.

[21]  Mitchel S. Berger,et al.  Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas , 2012, Science Translational Medicine.

[22]  Ovidiu C. Andronesi,et al.  Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy , 2012, Science Translational Medicine.

[23]  Kristen Scott,et al.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma , 2012, NeuroImage.

[24]  Dinesh Rakheja,et al.  2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients , 2011, Nature Medicine.

[25]  P. Boesiger,et al.  A multi-sample 94 GHz dissolution dynamic-nuclear-polarization system. , 2012, Journal of magnetic resonance.

[26]  Y. Xiong,et al.  IDH 1 and IDH 2 Mutations in Tumorigenesis : Mechanistic Insights and Clinical Perspectives , 2012 .

[27]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[28]  Neil Clarke,et al.  Dynamic nuclear polarization polarizer for sterile use intent , 2011, NMR in biomedicine.

[29]  P. Larson,et al.  In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-(13)C]alanine. , 2011, Magnetic resonance imaging.

[30]  C. Brennan,et al.  Molecular subclassification of diffuse gliomas: Seeing order in the chaos , 2011, Glia.

[31]  R. Vijayaraghavan,et al.  Toxicity of alpha-ketoglutarate following 14-days repeated oral administration in Wistar rats. , 2011, Cellular and molecular biology.

[32]  Sarah J Nelson,et al.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI , 2011, NMR in biomedicine.

[33]  C. James,et al.  Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging , 2011, Journal of magnetic resonance imaging : JMRI.

[34]  John Kurhanewicz,et al.  Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.

[35]  James B. Mitchell,et al.  Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imaging , 2011, Magnetic resonance in medicine.

[36]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[37]  Aaron E. Robinson,et al.  In vivo comparison of total and hyperpolarized lactate levels assessed by localized 1 H MRS and hyperpolarized 13 C MRSI in glioblastoma models at 14 . 1 Tesla , 2011 .

[38]  S. Ronen,et al.  17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2 , 2010, Breast Cancer Research.

[39]  K. Uğurbil,et al.  In vivo 13C spectroscopy in the rat brain using hyperpolarized [1-(13)C]pyruvate and [2-(13)C]pyruvate. , 2010, Journal of magnetic resonance.

[40]  Adolf Pfefferbaum,et al.  Metabolic imaging in the anesthetized rat brain using hyperpolarized [1‐13C] pyruvate and [1‐13C] ethyl pyruvate , 2010, Magnetic resonance in medicine.

[41]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[42]  Adam B Kerr,et al.  Investigation of tumor hyperpolarized [1‐13C]‐pyruvate dynamics using time‐resolved multiband RF excitation echo‐planar MRSI , 2010, Magnetic resonance in medicine.

[43]  John Kurhanewicz,et al.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. , 2010, Cancer research.

[44]  Ilwoo Park,et al.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. , 2010, Neuro-oncology.

[45]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[46]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[47]  Sarah E Bohndiek,et al.  Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors , 2009, Proceedings of the National Academy of Sciences.

[48]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[49]  Peder E. Z. Larson,et al.  Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. , 2008, Journal of magnetic resonance.

[50]  John Kurhanewicz,et al.  Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. , 2008, Magnetic resonance imaging.

[51]  John M Pauly,et al.  Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.

[52]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[53]  John M Pauly,et al.  Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. , 2007, Journal of magnetic resonance.

[54]  E. Gottlieb,et al.  Cell-Permeating α-Ketoglutarate Derivatives Alleviate Pseudohypoxia in Succinate Dehydrogenase-Deficient Cells , 2007, Molecular and Cellular Biology.

[55]  Jan Henrik Ardenkjaer-Larsen,et al.  Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. , 2006, Cancer research.

[56]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Lamborn,et al.  Growth of human glioblastomas as xenografts in the brains of athymic rats. , 2002, In Vivo.

[58]  H. Fatania,et al.  Chemical modification of rat liver cytosolic NADP+‐linked isocitrate dehydrogenase by N‐ethylmaleimide Evidence for essential sulphydryl groups , 1993, FEBS letters.

[59]  R. Shank,et al.  2-Oxoglutarate Transport: Regulating Glutamate and Intermediates in Neurons* A Potential Mechanism for Tricarboxylic Acid Cycle , 1993 .